SEVELAMER HYDROCHLORIDE (sevelamer hydrochloride) by Ichnos Glenmark Innovation is hydrochloride, a non-absorbed binding crosslinked polymer. First approved in 2019.
Drug data last refreshed 21h ago
hydrochloride, a non-absorbed binding crosslinked polymer. It contains multiple amines separated by one carbon from the polymer backbone. These amines exist in a protonated form in the intestine and interact with phosphate molecules through ionic and hydrogen bonding. By binding phosphate in the…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Head to Head Study Against Sevelamer Hydrochloride
Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis
Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate
Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease
Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
Worked on SEVELAMER HYDROCHLORIDE at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.